Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Verisign, Inc. (VRSN) vs Xylem, Inc. (XYL) Price & Performance

Verisign, Inc.Trade
Xylem, Inc.Trade

Price performance (Past 24H)

Key statistics

Verisign, Inc. vs Xylem, Inc. — how do they compare? Verisign, Inc. trades at $303.74 (market cap $26.92B), while Xylem, Inc. trades at $102.71 (market cap $23.81B). The key difference: Verisign, Inc. and Xylem, Inc. are close in size by market cap, and Xylem, Inc. pays the higher dividend (1.69%). Which is the better fit depends on your goals — on Pluang, investors hold Verisign, Inc. for 123 Days and Xylem, Inc. for 50 Days on average.

VRSNXYL
Market Cap
$26.92B$23.81B
Volume
1,921,4022,234,713
Sector
TechnologyIndustrials
52-Week High
$310.00$152.95
52-Week Low
$211.49$100.92
Typical Hold Time
123 Days50 Days
Enterprise Value
$28.23B$25.59B
Dividend Yield
1.09%1.69%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Verisign, Inc.

VeriSign (VRSN) trades at $303.74, up 3.24% today, with a bullish technical outlook supported by moving averages. The stock shows strong profitability with a 49.77% net income margin and consistent revenue growth, reaching $1.66B in 2025. Recent news includes an upcoming Q3 2026 earnings call and insider selling by the CEO, while institutional buying from firms like BlackRock signals confidence. A class-action antitrust lawsuit filed in September 2026 poses a regulatory risk.

The investment outlook is positive, driven by analyst consensus favoring a buy rating with a $348 price target, implying 15% upside. Key opportunities include AI-driven domain growth and a pending .com price increase. Risks involve the antitrust litigation, competitive pressures, and reliance on domain registry revenues. Earnings momentum is mixed, with Q2 2026 missing estimates but Q1 beating expectations.

Xylem, Inc.

XYL trades at $102.71, up 0.86% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported revenue of $9.04B in 2025 with a net income margin of 10.59%, and has beaten EPS estimates in recent quarters. Recent developments include a $1.5B senior note offering to fund acquisitions of Cornell Pump and Roper Pump, and the appointment of a new CFO.

Outlook is supported by strong water-solutions demand and margin expansion, but risks include China weakness and higher debt. Analysts are mixed with a consensus price target of $149.13, implying significant upside from current levels, though near-term technical pressure may persist.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

VRSN
50% Buy50% Sell
Avg holding period · 123 Days
XYL
100% Buy0% Sell
Avg holding period · 50 Days

About Verisign, Inc.

Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.

Read more on VRSN →

About Xylem, Inc.

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.

Read more on XYL →